1046 related articles for article (PubMed ID: 19917704)
21. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
Pankewycz O; Strom TB; Rubin-Kelley VE
Eur J Immunol; 1991 Apr; 21(4):873-9. PubMed ID: 1902177
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
[TBL] [Abstract][Full Text] [Related]
23. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
[TBL] [Abstract][Full Text] [Related]
24. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
[TBL] [Abstract][Full Text] [Related]
25. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
Kägi D; Ho A; Odermatt B; Zakarian A; Ohashi PS; Mak TW
J Immunol; 1999 Apr; 162(8):4598-605. PubMed ID: 10201999
[TBL] [Abstract][Full Text] [Related]
26. Establishment of islet-specific T-cell lines and clones from islet isografts placed in spontaneously diabetic NOD mice.
Wegmann DR; Shehadeh N; Lafferty KJ; Norbury-Glaser M; Gill RG; Daniel D
J Autoimmun; 1993 Oct; 6(5):517-27. PubMed ID: 7902094
[TBL] [Abstract][Full Text] [Related]
27. RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes.
Serra P; Amrani A; Han B; Yamanouchi J; Thiessen SJ; Santamaria P
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15566-71. PubMed ID: 12432095
[TBL] [Abstract][Full Text] [Related]
28. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
29. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
30. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice.
Wegmann DR; Norbury-Glaser M; Daniel D
Eur J Immunol; 1994 Aug; 24(8):1853-7. PubMed ID: 8056042
[TBL] [Abstract][Full Text] [Related]
31. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
[TBL] [Abstract][Full Text] [Related]
32. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.
Daniel D; Gill RG; Schloot N; Wegmann D
Eur J Immunol; 1995 Apr; 25(4):1056-62. PubMed ID: 7537670
[TBL] [Abstract][Full Text] [Related]
33. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.
Balasa B; Lee J; Sarvetnick N
Cell Immunol; 1999 May; 193(2):170-8. PubMed ID: 10222059
[TBL] [Abstract][Full Text] [Related]
34. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population.
Amrani A; Verdaguer J; Serra P; Tafuro S; Tan R; Santamaria P
Nature; 2000 Aug; 406(6797):739-42. PubMed ID: 10963600
[TBL] [Abstract][Full Text] [Related]
35. Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout.
Jasinski JM; Yu L; Nakayama M; Li MM; Lipes MA; Eisenbarth GS; Liu E
Diabetes; 2006 Jul; 55(7):1978-84. PubMed ID: 16804066
[TBL] [Abstract][Full Text] [Related]
36. Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity.
Schloot NC; Daniel D; Norbury-Glaser M; Wegmann DR
J Autoimmun; 1996 Jun; 9(3):357-63. PubMed ID: 8816971
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of the T-cell receptor V beta 5 and V beta 8 repertoire in pancreatic lesions of autoimmune diabetic NOD mice.
Berschick P; Fehsel K; Weltzien HU; Kolb H
J Autoimmun; 1993 Aug; 6(4):405-22. PubMed ID: 8216686
[TBL] [Abstract][Full Text] [Related]
38. Prevention of recurrent diabetes in syngenic islet-transplanted NOD mice by transfusion of autoreactive T lymphocytes.
Utsugi T; Nagata M; Kawamura T; Yoon JW
Transplantation; 1994 Jun; 57(12):1799-804. PubMed ID: 7912459
[TBL] [Abstract][Full Text] [Related]
39. Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes.
Millet I; Wong FS; Gurr W; Wen L; Zawalich W; Green EA; Flavell RA; Sherwin RS
J Autoimmun; 2006 Feb; 26(1):7-15. PubMed ID: 16338119
[TBL] [Abstract][Full Text] [Related]
40. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]